Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-25 @ 2:15 AM
NCT ID:
NCT02094560
Eligibility Criteria:
Inclusion Criteria:
* Histologically- or cytologically-confirmed, advanced disease with documented progression (RECIST1.1.) after one or several chemotherapy line
* Patients may also have received molecular targeted therapy and progressed while on therapy or after completion
* Must have recovered from the acute reversible effects of previous anti-cancer chemotherapy, usually 3-4 weeks after myelosuppressive chemotherapy
Exclusion Criteria:
* Serious concurrent medical condition, which could affect compliance with the protocol or interpretation of results.
* Patients with uncontrolled infection and patients known to be infected with the human immunodeficiency virus (HIV) or hepatitis infection are not eligible for the study
* Pregnancy or breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02094560
Study Brief:
Protocol Section:
NCT02094560